Cypriot group develops non-invasive, prenatal Down syndrome dx; creates startup to market test |
10/03/2011 |
(Genomeweb) The test, from researchers at the Cyprus Institute of Neurology and Genetics, combines methylated DNA immunoprecipitation and quantitative real-time PCR, and has demonstrated 100 percent sensitivity and specificity... [link to article]
|